Andy Abril

5.2k total citations
62 papers, 941 citations indexed

About

Andy Abril is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, Andy Abril has authored 62 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 26 papers in Rheumatology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Andy Abril's work include Vasculitis and related conditions (25 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers) and Eosinophilic Disorders and Syndromes (12 papers). Andy Abril is often cited by papers focused on Vasculitis and related conditions (25 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers) and Eosinophilic Disorders and Syndromes (12 papers). Andy Abril collaborates with scholars based in United States, Colombia and Canada. Andy Abril's co-authors include Marc D. Cohen, Kenneth Calamia, William W. Ginsburg, Isabel Mira‐Avendano, José A. Gómez‐Puerta, Mark J. Kransdorf, John A. Doyle, Scott T. Persellin, Eric L. Matteson and José Luís Ayuso‐Mateos and has published in prestigious journals such as The Lancet, The American Journal of Medicine and Annals of the Rheumatic Diseases.

In The Last Decade

Andy Abril

59 papers receiving 908 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andy Abril United States 18 473 438 195 163 149 62 941
Éric Houvenagel France 20 187 0.4× 622 1.4× 128 0.7× 182 1.1× 166 1.1× 68 1.3k
U. Michon-Pasturel France 15 409 0.9× 357 0.8× 357 1.8× 64 0.4× 397 2.7× 56 1.1k
S. Morell‐Dubois France 19 379 0.8× 363 0.8× 210 1.1× 83 0.5× 672 4.5× 62 1.4k
P. Cohen France 11 252 0.5× 190 0.4× 98 0.5× 101 0.6× 42 0.3× 20 558
Seerapani Gopaluni United Kingdom 14 500 1.1× 245 0.6× 81 0.4× 147 0.9× 54 0.4× 28 692
C. Tolédano France 13 156 0.3× 126 0.3× 162 0.8× 94 0.6× 301 2.0× 46 761
James V. Dunne Canada 17 447 0.9× 112 0.3× 245 1.3× 128 0.8× 550 3.7× 33 997
Yasemin Kabasakal Türkiye 19 110 0.2× 285 0.7× 92 0.5× 305 1.9× 234 1.6× 47 883
Abdullah Al-Dalaan Saudi Arabia 21 173 0.4× 597 1.4× 102 0.5× 54 0.3× 103 0.7× 42 1.2k
Mara Felicetti Italy 16 239 0.5× 323 0.7× 48 0.2× 104 0.6× 43 0.3× 53 742

Countries citing papers authored by Andy Abril

Since Specialization
Citations

This map shows the geographic impact of Andy Abril's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Abril with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Abril more than expected).

Fields of papers citing papers by Andy Abril

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Abril. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Abril. The network helps show where Andy Abril may publish in the future.

Co-authorship network of co-authors of Andy Abril

This figure shows the co-authorship network connecting the top 25 collaborators of Andy Abril. A scholar is included among the top collaborators of Andy Abril based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy Abril. Andy Abril is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eshak, Nouran, Felipe Martinez, Carolyn Mead‐Harvey, et al.. (2025). Role of F-18 FDG-PET CT scan in the evaluation of medium vessel vasculitis. Seminars in Arthritis and Rheumatism. 75. 152864–152864.
2.
Soni, Anushka, et al.. (2024). Distribution of Airway Findings in ANCA-Associated Vasculitis: A 20-Year Observational Analysis. Diagnostics. 15(1). 74–74. 2 indexed citations
3.
Abril, Andy, et al.. (2024). Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Research & Therapy. 26(1). 4–4. 1 indexed citations
4.
Abril, Andy, et al.. (2024). Digital Ulcers and Microvascular Abnormalities Presenting As the Initial Manifestations of Pre-scleroderma. Cureus. 16(12). e75061–e75061. 1 indexed citations
5.
Rivera, Fernando A., David O. Hodge, Benjamin Wang, et al.. (2024). A retrospective analysis of the prevalence and impact of associated comorbidities on fibromyalgia outcomes in a tertiary care center. Frontiers in Medicine. 10. 1301944–1301944. 5 indexed citations
6.
Majithia, Vikas, et al.. (2024). Investigating the concomitance of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitides and inflammatory bowel disease (IBD). Seminars in Arthritis and Rheumatism. 66. 152452–152452. 3 indexed citations
7.
Wang, Benjamin, et al.. (2023). Dermatomyositis in Association With SARS‐CoV‐2 Infection or COVID‐19 Vaccine. Arthritis Care & Research. 76(1). 98–104. 4 indexed citations
8.
Abril, Andy, et al.. (2023). Diffuse alveolar hemorrhage secondary to sarcoidosis. Clinical Rheumatology. 42(6). 1701–1704. 2 indexed citations
9.
Crowson, Cynthia S., Andy Abril, Benjamin Wang, et al.. (2023). Relapse Risk and Safety of Long-Term Tocilizumab Use Among Patients With Giant Cell Arteritis: A Single-Enterprise Cohort Study. The Journal of Rheumatology. 50(10). 1310–1317. 13 indexed citations
10.
Muntyanu, Anastasiya, Deborah Assayag, Andy Abril, et al.. (2022). Skin disorders and interstitial lung disease: Part II—The spectrum of cutaneous diseases with lung disease association. Journal of the American Academy of Dermatology. 88(4). 767–782. 3 indexed citations
11.
Springer, Jason, Mohamad A. Kalot, Nedaa Husainat, et al.. (2021). Granulomatosis With Polyangiitis and Microscopic Polyangiitis: A Systematic Review and Meta‐Analysis of Benefits and Harms of Common Treatments. ACR Open Rheumatology. 3(3). 196–205. 10 indexed citations
12.
Abril, Andy, et al.. (2020). Lupus Vasculitis. Current Rheumatology Reports. 22(10). 71–71. 21 indexed citations
13.
Abril, Andy, et al.. (2020). An alternative approach against eosinophils for the treatment of eosinophilic granulomatosis with polyangiitis. The Journal of Allergy and Clinical Immunology In Practice. 8(6). 2079–2080. 4 indexed citations
14.
Mertz, Lester E., et al.. (2019). Demographic, Clinical, and Radiologic Characteristics of a Cohort of Patients with Takayasu Arteritis. The American Journal of Medicine. 132(5). 647–651. 20 indexed citations
15.
Sluzevich, Jason C., et al.. (2018). Association of antinuclear antibody status with clinical features and malignancy risk in adult-onset dermatomyositis. Journal of the American Academy of Dermatology. 80(5). 1364–1370. 21 indexed citations
16.
Mira‐Avendano, Isabel & Andy Abril. (2015). Pulmonary Manifestations of Sjögren Syndrome, Systemic Lupus Erythematosus, and Mixed Connective Tissue Disease. Rheumatic Disease Clinics of North America. 41(2). 263–277. 13 indexed citations
17.
Abril, Andy, et al.. (2015). Seizing the clinical presentation in adult onset Still's disease. An extensive literature review. Autoimmunity Reviews. 14(5). 472–477. 23 indexed citations
18.
Abril, Andy, et al.. (2015). MDS and GCA: a prognostic dilemma. Clinical Rheumatology. 35(3). 807–812. 1 indexed citations
19.
Martínez‐Martínez, Marco Ulises, Jorge Alcocer‐Varela, Javier Merayo‐Chalico, et al.. (2014). Factors Associated with Mortality and Infections in Patients with Systemic Lupus Erythematosus with Diffuse Alveolar Hemorrhage. The Journal of Rheumatology. 41(8). 1656–1661. 43 indexed citations
20.
Abril, Andy, et al.. (2013). Idiopathic Arthritis Mutilans. The Journal of Rheumatology. 40(11). 1921–1922. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Éric Houvenagel Breakdown of academic impact, for papers by U. Michon-Pasturel Breakdown of academic impact, for papers by S. Morell‐Dubois Breakdown of academic impact, for papers by P. Cohen Breakdown of academic impact, for papers by Seerapani Gopaluni Breakdown of academic impact, for papers by C. Tolédano Breakdown of academic impact, for papers by James V. Dunne Breakdown of academic impact, for papers by Yasemin Kabasakal Breakdown of academic impact, for papers by Abdullah Al-Dalaan Breakdown of academic impact, for papers by Mara Felicetti
Rankless by CCL
2026